S100B and lactate dehydrogenase as response and progression markers during treatment with vemurafenib in patients with advanced melanoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

S100B and lactate dehydrogenase as response and progression markers during treatment with vemurafenib in patients with advanced melanoma

Published:2013-10 Issue:5 Volume:23 Page:396-401
ISSN:0960-8931
Container-title:Melanoma Research
language:en
Short-container-title:

Author:

Abusaif Sail,Jradi Zeinab,Held Laura,Pflugfelder Annette,Weide Benjamin,Meier Friedegund,Garbe Claus,Eigentler Thomas K.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Dermatology,Oncology

Reference5 articles.

1. Biological effects of low dose radiation from computed tomography scanning.;Shumei;Int J Radiat Biol,2012

2. Loss of S100 antigenicity in metastatic melanoma.;Aisner;Hum Pathol,2005

3. LDH and melanoma.;Finck;Cancer,1983

4. Regression analyses of prognostic factors in metastatic malignant melanoma.;Heimdal;Eur J Cancer Clin Oncol,1989

5. Elevated serum levels of the glial marker protein S100B are not specific for schizophrenia or mood disorders.;Schroeter;Mol Psychiatry,2009

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictive Performance of Serum S100B Versus LDH in Melanoma Patients: A Systematic Review and Meta-Analysis;Frontiers in Oncology;2021-12-07

2. Serum S100B and LDH at Baseline and During Therapy Predict the Outcome of Metastatic Melanoma Patients Treated with BRAF Inhibitors;Targeted Oncology;2021-02-08

3. Relative Change in S100 as a Biomarker of Survival in Patients With Metastatic Melanoma Treated With Pembrolizumab;Anticancer Research;2020-03-31

4. Biomarkers Predictive of Survival and Response to Immune Checkpoint Inhibitors in Melanoma;American Journal of Clinical Dermatology;2019-10-10

5. Current analytical approaches in diagnosis of melanoma;TrAC Trends in Analytical Chemistry;2019-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3